Green Alpha Advisors’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $536K | Sell |
425,679
-6,646
| -2% | -$8.37K | 0.51% | 62 |
|
|
2025
Q1 | $395K | Buy |
432,325
+251,271
| +139% | +$229K | 0.42% | 72 |
|
|
2024
Q4 | $288K | Buy |
181,054
+77,840
| +75% | +$124K | 0.23% | 115 |
|
|
2024
Q3 | $202K | Buy |
103,214
+25,843
| +33% | +$50.7K | 0.16% | 122 |
|
|
2024
Q2 | $127K | Sell |
77,371
-6,150
| -7% | -$10.1K | 0.1% | 130 |
|
|
2024
Q1 | $429K | Buy |
83,521
+3,957
| +5% | +$20.3K | 0.31% | 107 |
|
|
2023
Q4 | $456K | Sell |
79,564
-30,960
| -28% | -$177K | 0.33% | 112 |
|
|
2023
Q3 | $528K | Buy |
110,524
+4,698
| +4% | +$22.5K | 0.41% | 91 |
|
|
2023
Q2 | $450K | Buy |
105,826
+21,359
| +25% | +$90.8K | 0.3% | 114 |
|
|
2023
Q1 | $449K | Buy |
84,467
+9,360
| +12% | +$49.7K | 0.31% | 111 |
|
|
2022
Q4 | $472K | Buy |
75,107
+5,731
| +8% | +$36K | 0.39% | 102 |
|
|
2022
Q3 | $732K | Sell |
69,376
-182,896
| -72% | -$1.93M | 0.62% | 71 |
|
|
2022
Q2 | $1.37M | Buy |
252,272
+202,598
| +408% | +$1.1M | 0.31% | 64 |
|
|
2022
Q1 | $456K | Buy |
49,674
+14,082
| +40% | +$129K | 0.31% | 110 |
|
|
2021
Q4 | $537K | Buy |
35,592
+2,756
| +8% | +$41.6K | 0.36% | 105 |
|
|
2021
Q3 | $784K | Buy |
+32,836
| New | +$784K | 0.54% | 96 |
|